Tirzepatide in MetALD
Abroad (travel likely)RecruitingPHASE2
Conditions
Metabolic Alcohol-associated Liver Disease · Alcohol Use Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (NIH Clinical Center Office of Patient Recruitment (OPR) · ccopr@nih.gov · 800-411-1222Contact: Study coordinator (Section on Clinical Genomics & Experimental Therapeutics) · NIAAACGETResearch@mail.nih.gov · (240) 731-9681
Study leads
Falk W Lohoff, M.D.
Principal Investigator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)